Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
This study is currently recruiting participants.
Verified January 2013 by Mayo Clinic
Study NCT00670358
Information provided by Mayo Clinic
First Received on April 30, 2008.
Last Updated on January 16, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
